The AHSN Network, working in partnership with the Accelerated Access Collaborative (AAC) and NICE has published a clinically approved pathway to support secondary care clinicians to optimise lipid management following an acute cardiovascular event.
Cardiovascular disease (CVD) is a leading cause of premature death and disability due to the consequences of stroke, heart attack (myocardial infarction), and heart failure. The pathway provides clear and unified guidance for clinicians on how optimal lipid management may be achieved, to reduce the risk of further cardiovascular events.
The Lipid management pathways for primary care and secondary care clinicians includes additional medications to use alongside statins, including novel LDL-cholesterol lowering therapies such as the PCSK9i drugs and Inclisiran. These new cholesterol-lowering drugs are important additional tools for managing cardiovascular disease.
A supplementary pathway has also been published to give clearer guidance on lipid optimisation following an acute cardiovascular event for healthcare professionals working within secondary care.
Professor Nick Linker, National Clinical Director for Heart Disease at NHS England and NHS Improvement said: “The ‘Lipid optimisation pathway following an acute cardiovascular event’ provides a clear and simple guide for clinicians to ensure optimal lipid management is achieved for patients. The pathway enables healthcare professionals to implement best practice principles in line with NICE guidance and further supports the prevention of secondary cardiovascular events.”
The AHSN Network supports the NHS in the prevention and management of cardiovascular disease through its National Lipid Management and Familial Hypercholesterolaemia (FH) programme of work, which is delivered in partnership with the Accelerated Access Collaborative (AAC).
We are delighted to publish the Innovation for Healthcare Inequalities Programme (InHIP) impact and learning report. NHS England’s InHIP programme is a collaboration between the Accelerated Access Collaborative (AAC), NHS England’s National Healthcare Inequalities Improvement Programme and the Health Innovation Network, delivered in partnership with integrated care systems (ICSs). It aims to address local healthcare [...]
Download our Impact Report In 2023-24, as a Network, we delivered national programmes and initiatives that benefitted over 1,228,000 patients, created wealth and health by leveraging £467m through our support to innovators, and worked alongside health and care teams to tackle some of the NHS’s most pressing challenges including cardiovascular disease, patient safety and [...]
We are delighted to welcome Dr Dominique Allwood as the new Chief Executive Officer for Imperial College Health Partners (ICHP). Dominique joins ICHP from neighbouring health innovation network UCLPartners, where she is currently Chief Medical Officer. Her focus is on clinical engagement across the partnership and with the Health Innovation Network Clinical Executives in her [...]
